The stock of Adicet Bio Inc (ACET) has seen a -13.69% decrease in the past week, with a -36.40% drop in the past month, and a -51.67% decrease in the past quarter. The volatility ratio for the week is 11.55%, and the volatility levels for the past 30 days are at 7.95% for ACET. The simple moving average for the past 20 days is -26.36% for ACET’s stock, with a -26.83% simple moving average for the past 200 days.
Is It Worth Investing in Adicet Bio Inc (NASDAQ: ACET) Right Now?
The 36-month beta value for ACET is also noteworthy at 1.97. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACET is 67.18M, and at present, short sellers hold a 11.69% of that float. The average trading volume of ACET on May 06, 2024 was 1.40M shares.
ACET) stock’s latest price update
Adicet Bio Inc (NASDAQ: ACET)’s stock price has plunge by 2.84relation to previous closing price of 1.41. Nevertheless, the company has seen a -13.69% plunge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-04 that Adicet Bio (ACET) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Analysts’ Opinion of ACET
JP Morgan gave a rating of “Neutral” to ACET, setting the target price at $6 in the report published on June 01st of the previous year.
ACET Trading at -32.86% from the 50-Day Moving Average
After a stumble in the market that brought ACET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.67% of loss for the given period.
Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 11.55%, as shares sank -35.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.57% lower at present.
During the last 5 trading sessions, ACET fell by -13.69%, which changed the moving average for the period of 200-days by -54.97% in comparison to the 20-day moving average, which settled at $1.9290. In addition, Adicet Bio Inc saw -23.28% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACET starting from ORBIMED ADVISORS LLC, who purchase 3,125,000 shares at the price of $2.40 back on Jan 25 ’24. After this action, ORBIMED ADVISORS LLC now owns 7,526,359 shares of Adicet Bio Inc, valued at $7,500,000 using the latest closing price.
GORDON CARL L, the Director of Adicet Bio Inc, purchase 3,125,000 shares at $2.40 during a trade that took place back on Jan 25 ’24, which means that GORDON CARL L is holding 7,526,359 shares at $7,500,000 based on the most recent closing price.
Stock Fundamentals for ACET
The total capital return value is set at -0.81. Equity return is now at value -61.69, with -53.03 for asset returns.
Based on Adicet Bio Inc (ACET), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -4.48. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -6335.0.
Currently, EBITDA for the company is -126.48 million with net debt to EBITDA at 1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.41.
Conclusion
In summary, Adicet Bio Inc (ACET) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
